Seroepidemiology of pertussis in the adult population of Singapore

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 11, 2006, Pages 780-782

  Wilder Smith, Annelise ^a   Ng, S ^a   Earnest, Arul ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Acellular pertussis vaccine; Adolescent pertussis seroprevalence; Pertussis booster vaccine; Pertussis seroepidemiology; Whooping cough

Indexed keywords

CELL ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; VACCINE;

ADULT; AGED; ARTICLE; BORDETELLA PERTUSSIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; POPULATION RESEARCH; RACE DIFFERENCE; SEROEPIDEMIOLOGY; SEX DIFFERENCE; SINGAPORE;

EID: 33846012883     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32:1691-7.
2. Wright SW. Pertussis infection in adults. South Med J 1998:91:702-8; quiz 709.
3. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 1999;28 Suppl 2:S118-S123.
4. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464-71.
5. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4.
6. Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004;39:20-8.
7. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001;183:1353-9.
8. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555-63.
9. Wirsing von Konig CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995;346:1326-9.
10. Keitel WA, Edwards KM. Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect 1995;10:51-7.
11. Mertens PL, Stals FS, Schellekens JF, Houben AW, Huisman J. An epidemic of pertussis among elderly people in a religious institution in The Netherlands. Eur J Clin Microbiol Infect Dis 1999;18:242-7.
12. Pichichero ME, Treanor J. Economic impact of pertussis. Arch Pediatr Adolesc Med 1997;151:35-40.
13. Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987;9:866-83.
14. Fine PE, Clarkson JA, Miller E. The efficacy of pertussis vaccines under conditions of household exposure. Further analysis of the 1978-80 PHLS/ERL study in 21 area health authorities in England. Int J Epidemiol 1988;17:635-42.
15. Campins-Marti M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001;20:641-6.
16. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996;173:1256-9.
17. Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-3):1-34.
18. Chan SH, Tan PT, Han HH, Bock HL. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Singapore Med J 2006;47:286-90.
19. Wharton M. Prevention of pertussis among adolescents by vaccination: taking action on what we know and acknowledging what we do not know. Clin Infect Dis 2004;39:29-30.
20. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002;2:744-50.
21. Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, et al. Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece. J Clin Lab Anal 2004;18:211-4.
22. Dominguez A, Vidal J, Plans P, Salleras L. The seroepidemiology of B. pertussis infection in Catalonia, Spain. Epidemiol Infect 2001;126:205-10.
23. Goh KT. The national childhood immunisation programmes in Singapore. Singapore Med J 1985;26:225-42.
24. Wilder-Smith A, Earnest A, Ravindran S, Paton NI. High incidence of pertussis among Hajj pilgrims. Clin Infect Dis 2003;37:1270-2.
25. Committee on Epidemic Diseases. Prevalence of pertussis antibody in children and adults in Singapore. Epidemiological News Bull 1995;21:65-7.
26. Arav-Boger R, Ashkenazi S, Gdalevich M, Cohen D, Danon YL. Seroprevalence of pertussis antibodies among adolescents in Israel. Isr Med Assoc J 2000;2:174-7.
27. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-7.
28. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000;182:1409-16.
29. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002;185:1448-53.